-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q1 2023.
- Sangamo Therapeutics, Inc Return On Equity for the quarter ending March 31, 2023 was -40.4 %, a 10.5% increase year-over-year.
- Sangamo Therapeutics, Inc annual Return On Equity for 2022 was -61.2 %, a 45.5% decline from 2021.
- Sangamo Therapeutics, Inc annual Return On Equity for 2021 was -42 %, a 67.1% decline from 2020.
- Sangamo Therapeutics, Inc annual Return On Equity for 2020 was -25.2 %, a 7.52% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)